Desmopressin Tablets |
DDAVP Tablets |
Clinical Trial: The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women
This study is currently recruiting patients.
Verified by Solvay Pharmaceuticals August 2005
|
Purpose
| Condition | Intervention | Phase |
|---|---|---|
| Menopause | Drug: esterified estrogens 1.25mg and methyltestosterone 2.5mg | Phase II |
MedlinePlus consumer health information
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title: A Multi-Center, Double-Blind Study to Determine the Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women
Eligibility
Inclusion Criteria:
Hysterectomized, menopausal women between the ages of 30 and 65 years of age (inclusive) with symptoms of estrogen and/or androgen deficiency not currently controlled by estrogen therapy as determined by patient report and the Investigator''''s clinical judgement
Exclusion Criteria:
-
Location and Contact Information
Alabama
Site 46, Montgomery, Alabama, United States; Recruiting
Site 57, Mobile, Alabama, United States; Recruiting
Site 66, Huntsville, Alabama, United States; Recruiting
Arizona
Site 15, Tucson, Arizona, United States; Recruiting
Site 29, Phoenix, Arizona, United States; Recruiting
Arkansas
Site 3, Jonesboro, Arkansas, United States; Recruiting
Site 22, Little Rock, Arkansas, United States; Recruiting
California
Site 6, San Diego, California, United States; Recruiting
Site 25, Walnut Creek, California, United States; Recruiting
Site 45, Santa Rosa, California, United States; Recruiting
Site 55, Encinitas, California, United States; Recruiting
Site 68, Carmichael, California, United States; Recruiting
Colorado
Site 26, Denver, Colorado, United States; Recruiting
Connecticut
Site 1, Groton, Connecticut, United States; Recruiting
Site 30, Trumbull, Connecticut, United States; Recruiting
Site 34, Waterbury, Connecticut, United States; Recruiting
Site 54, Hartford, Connecticut, United States; Recruiting
Florida
Site 10, Aventura, Florida, United States; Recruiting
Site 11, Pinellas Park, Florida, United States; Recruiting
Site 17, West Palm Beach, Florida, United States; Recruiting
Site 27, Palm Springs, Florida, United States; Recruiting
Site 49, Melbourne, Florida, United States; Recruiting
Site 51, Leesburg, Florida, United States; Recruiting
Site 61, Ocala, Florida, United States; Recruiting
Site 64, New Port Richey, Florida, United States; Recruiting
Site 69, St. Petersburg, Florida, United States; Recruiting
Site 70, Venice, Florida, United States; Recruiting
Site 73, Ft. Myers, Florida, United States; Recruiting
Site 75, Sarasota, Florida, United States; Recruiting
Georgia
Site 5, Atlanta, Georgia, United States; Recruiting
Site 7, Savannah, Georgia, United States; Recruiting
Site 9, Riverdale, Georgia, United States; Recruiting
Site 44, Decatur, Georgia, United States; Recruiting
Site 50, Alpharetta, Georgia, United States; Recruiting
Site 77, Douglasville, Georgia, United States; Recruiting
Idaho
Site 47, Boise, Idaho, United States; Recruiting
Illinois
Site 20, Chicago, Illinois, United States; Recruiting
Site 24, Champaign, Illinois, United States; Recruiting
Site 76, Peoria, Illinois, United States; Recruiting
Indiana
Site 58, Evansville, Indiana, United States; Recruiting
Kansas
Site 39, Wichita, Kansas, United States; Recruiting
Louisiana
Site 52, New Orleans, Louisiana, United States; Recruiting
Site 59, Baton Rouge, Louisiana, United States; Recruiting
Michigan
Site 53, Ann Arbor, Michigan, United States; Recruiting
Missouri
Site 32, Richmond Heights, Missouri, United States; Recruiting
Site 36, St. Louis, Missouri, United States; Recruiting
Site 63, Kansas City, Missouri, United States; Recruiting
Montana
Site 72, Billings, Montana, United States; Recruiting
Nebraska
Site 21, Lincoln, Nebraska, United States; Recruiting
Nevada
Site 37, Reno, Nevada, United States; Recruiting
North Carolina
Site 13, New Bern, North Carolina, United States; Recruiting
Site 16, Winston Salem, North Carolina, United States; Recruiting
Site 65, Cary, North Carolina, United States; Recruiting
Ohio
Site 60, Columbus, Ohio, United States; Recruiting
Oklahoma
Site 40, Tulsa, Oklahoma, United States; Recruiting
Site 67, Oklahoma City, Oklahoma, United States; Recruiting
Oregon
Site 33, Portland, Oregon, United States; Recruiting
Site 41, Medford, Oregon, United States; Recruiting
Site 62, Eugene, Oregon, United States; Recruiting
Pennsylvania
Site 18, Erie, Pennsylvania, United States; Recruiting
Site 19, Philadelphia, Pennsylvania, United States; Recruiting
Site 23, Pottstown, Pennsylvania, United States; Recruiting
South Carolina
Site 31, Anderson, South Carolina, United States; Recruiting
Site 35, Greer, South Carolina, United States; Recruiting
Tennessee
Site 4, Chattanooga, Tennessee, United States; Recruiting
Texas
Site 8, Corpus Christi, Texas, United States; Recruiting
Site 14, San Antonio, Texas, United States; Recruiting
Site 42, Houston, Texas, United States; Recruiting
Site 71, Dallas, Texas, United States; Recruiting
Site 74, Conroe, Texas, United States; Recruiting
Utah
Site 38, Salt Lake City, Utah, United States; Recruiting
Virginia
Site 12, Richmond, Virginia, United States; Recruiting
Site 28, Norfolk, Virginia, United States; Recruiting
Washington
Site 2, Seattle, Washington, United States; Recruiting
Site 43, Tacoma, Washington, United States; Recruiting
Site 48, Spokane, Washington, United States; Recruiting
Site 56, Renton, Washington, United States; Recruiting
Global Clinical Director Solvay, Study Director, Solvay Pharmaceuticals
More Information
Last Updated: August 31, 2005
Record first received: August 30, 2005
ClinicalTrials.gov Identifier: NCT00141557
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-09-06
Resources
- DDAVP Tablets (Drug Digest)
- Desmopressin Tablets (Drug Digest)

Not Signed In -


